GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Offering Completed - Earn an annual dividend of 8%, paid monthly. $500 minimum investment
Science Officer × Ron Zimmerman Co-Founder & Chief Science Officer Ron ... and characterization of therapeutic proteins. With offices, laboratories and production ... and bioequivalent protein products. David Wood President & Chief Executive Officer ...
Earn an annual dividend of 8%, paid monthly. $500 minimum investment
and officers; (iii) financial statements for the past two years (which do not need ...
GATC Health is transforming how we diagnose and treat disease.
Make an investment in IdentifySensors Biologics.
Invest in Fast-Growing Organic Agriculture Technology!
Earn an annual dividend of 8%, paid monthly. $500 minimum investment
and beverages. × Gerald (Jerry) Ellenburg Chairman and Chief Executive Officer ... Chief Marketing & Experience Officer John has 32 years in marketing, ... Operating Officer Nick is a seasoned executive with over 30 years ...